China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A study on the prediction of the efficacy of novel endocrine therapy for prostate cancer bone metastasis using multimodal image-based models'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136727
Registration Time: 2026/11/14
Type: Observational study
Primary Sponsor: The Second Affiliated hospital of Fujian Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=353431
Published by HT Digital Content Services with permission from Health Daily Digest....